Linking pages
- Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports - The New York Times https://www.nytimes.com/2024/04/17/health/sleep-apnea-obesity-zepbound.html 2 comments
- Inside Novo Nordisk, the Company Behind Ozempic and Wegovy - The New York Times https://www.nytimes.com/2024/04/20/business/ozempic-novo-nordisk-wegovy.html 1 comment
- Ozempic May Help Treat Kidney Disease, Study Finds - The New York Times https://www.nytimes.com/2024/05/24/well/ozempic-kidney-disease-semaglutide.html 0 comments
Linked pages
- The Race to Stop Ozempic Muscle Loss - The New York Times https://www.nytimes.com/2024/02/08/well/live/ozempic-muscle-loss-exercise.html 62 comments
- Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs - The New York Times https://www.nytimes.com/2024/01/26/business/obesity-drugs-insurance-north-carolina.html 28 comments
- Where Ozempic, Wegovy and New Weight Loss Drugs Came From - The New York Times https://www.nytimes.com/2023/08/17/health/weight-loss-drugs-obesity-ozempic-wegovy.html 7 comments
- Can Ozempic and Weight Loss Drugs Treat Other Diseases? - The New York Times https://www.nytimes.com/interactive/2023/12/20/well/live/ozempic-weight-loss-drugs-diseases.html 4 comments
- What Is Ozempic and Why Is It Getting So Much Attention? - The New York Times https://www.nytimes.com/2022/11/22/well/ozempic-diabetes-weight-loss.html 2 comments
- Risks of Ozempic, Wegovy and Other Weight Loss Drugs for People Over 65 - The New York Times https://www.nytimes.com/2023/07/17/well/ozempic-wegovy-risks-older.html 1 comment
- FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight | FDA https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or 0 comments
Related searches:
Search whole site: site:www.nytimes.com
Search title: Wegovy Approved By FDA to Reduce Heart Attack Risk - The New York Times
See how to search.